Furthermore, the standard does not recommend any other medication, but in case of mild bronchiolitis the natural course can be waited for. In the 2020 standard, the NHG recommended considering a trial treatment with a beta-2 sympathomimetic in cases of suspected bronchiolitis. Doctors could use this treatment in children with dyspnea if the clinical picture is difficult to distinguish from an asthma attack.
After an analysis of the latest studies, the NHG working group has come to different advice. Research shows that a short-acting beta-2 sympathomimetic may not or hardly reduce the risk of hospital admission compared to placebo. Side effects may occur. Because of these findings, the working group advises caution in prescribing bronchodilators via nebulization and inhalation with a spacer.
Stuffy nose
The new standard also includes advice on the treatment of a blocked nose in young children. Babies can only breathe through their nose until the age of 6 months. This means that they are less able to drink when they have a blocked nose, which in exceptional cases can lead to dehydration.
The NHG indicates that this can be prevented by administering a saline solution before every feeding. If this does not work sufficiently, doctors can prescribe xylometazoline nasal drops or nasal spray to children older than 3 months.
Viral infection
Bronchiolitis is an infection of the lower respiratory tract that leads to inflammation and narrowing of the small airways. The infection is caused by the same respiratory viruses that also cause acute coughing without bronchiolitis. These include RS (respiratory syncytial) virus and rhinovirus.
The disease occurs mainly in the autumn and winter season in children aged 2 years or younger. Patients may experience shortness of breath, wheezing and fever, and in severe cases hospitalization may be required.
2023-11-27 23:03:53
#Salbutamol #possibly #ineffective #bronchiolitis #Pharmaceutisch #Weekblad
